7-Jun, 11:00 - 11:30
The New Normal in Retail – Sales, Stock and Supply
As Australian consumers we're educated, taking charge of our health and actively looking for alternative solutions to both treat and prevent illness. Seventy-three percent of us are using complementary medicines regularly and it shows in our market, expected to reach $6 billion by 2023.
Accelerated in many ways by COVID-19 the industry now faces pandemic related supply chain challenges that impact us all. Complementary Medicines Australia CEO Carl Gibson and Industry Development Manager Cameron Thorpe look at the impact COVID-19 has had on the supply chain, challenges in accessing world class ingredients and what it means for both manufacturers, retailers and consumers now and into the future. They’ll share sales data across the industry, the chronic diseases driving growth, the innovations, trends - and the fads that have captivated us during the last year.